secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0000950170-24-046010
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE receives Nasdaq delisting notice for bid price non-compliance; hearing requested
--------------------------------------------------------------------------------

- Received Nasdaq Staff Letter on April 15, 2024, for failing $1.00 minimum bid price for 30 consecutive business days through March 1, 2024.
- Ineligible for automatic compliance period due to prior panel monitor (Aug 14, 2023) and reverse stock splits exceeding 250:1 cumulative over two years.
- Company will request a hearing before Nasdaq Hearings Panel; request automatically stays suspension/delisting pending hearing and panel decision.
- Panel may grant extension of compliance period up to October 14, 2024. Prior letter of March 4, 2024 was issued in error.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000095017024046010/0000950170-24-046010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000095017024046010/biol-20240419.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-046010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer